Abstract
In the Consortium on Resistance Against Carbapenems in Klebsiella and other Enterobacteriaceae (CRACKLE), trimethoprim-sulfamethoxazole (TMP-SMX) had a limited role in the treatment of less severe carbapenem-resistant Enterobacteriaceae (CRE) infections, especially urinary tract infections. Of tested CRE, only 29% were susceptible to TMPSMX. Development of resistance further limits the use of TMPSMX in CRE infections.
| Original language | English |
|---|---|
| Journal | Open Forum Infectious Diseases |
| Volume | 6 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 01-01-2019 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Oncology
- Clinical Neurology
Cite this
}
The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant Enterobacteriaceae. / Luterbach, Courtney L.; Boshe, Ashley; Henderson, Heather I.; Cober, Eric; Richter, Sandra S.; Salata, Robert A.; Kalayjian, Robert C.; Watkins, Richard R.; Hujer, Andrea M.; Hujer, Kristine M.; Rudin, Susan D.; Domitrovic, T. Nicholas; Doi, Yohei; Kaye, Keith S.; Evans, Scott; Fowler, Vance G.; Bonomo, Robert A.; Van Duin, David.
In: Open Forum Infectious Diseases, Vol. 6, No. 1, 01.01.2019.Research output: Contribution to journal › Article
TY - JOUR
T1 - The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant Enterobacteriaceae
AU - Luterbach, Courtney L.
AU - Boshe, Ashley
AU - Henderson, Heather I.
AU - Cober, Eric
AU - Richter, Sandra S.
AU - Salata, Robert A.
AU - Kalayjian, Robert C.
AU - Watkins, Richard R.
AU - Hujer, Andrea M.
AU - Hujer, Kristine M.
AU - Rudin, Susan D.
AU - Domitrovic, T. Nicholas
AU - Doi, Yohei
AU - Kaye, Keith S.
AU - Evans, Scott
AU - Fowler, Vance G.
AU - Bonomo, Robert A.
AU - Van Duin, David
PY - 2019/1/1
Y1 - 2019/1/1
N2 - In the Consortium on Resistance Against Carbapenems in Klebsiella and other Enterobacteriaceae (CRACKLE), trimethoprim-sulfamethoxazole (TMP-SMX) had a limited role in the treatment of less severe carbapenem-resistant Enterobacteriaceae (CRE) infections, especially urinary tract infections. Of tested CRE, only 29% were susceptible to TMPSMX. Development of resistance further limits the use of TMPSMX in CRE infections.
AB - In the Consortium on Resistance Against Carbapenems in Klebsiella and other Enterobacteriaceae (CRACKLE), trimethoprim-sulfamethoxazole (TMP-SMX) had a limited role in the treatment of less severe carbapenem-resistant Enterobacteriaceae (CRE) infections, especially urinary tract infections. Of tested CRE, only 29% were susceptible to TMPSMX. Development of resistance further limits the use of TMPSMX in CRE infections.
UR - http://www.scopus.com/inward/record.url?scp=85062192046&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85062192046&partnerID=8YFLogxK
U2 - 10.1093/ofid/ofy351
DO - 10.1093/ofid/ofy351
M3 - Article
VL - 6
JO - Open Forum Infectious Diseases
JF - Open Forum Infectious Diseases
SN - 2328-8957
IS - 1
ER -